Oncovision has grown into a dynamic brand in a technologically competitive, high-growth industry. Headquartered in Valencia, Spain, the company sells its products in over 30 markets through a combination of direct sales and distributors.

Oncovision has extensive experience in the development and commercialization of medical imaging equipment based on nuclear medicine techniques. Through a strong internal pipeline, its product line includes the market-leading Sentinella, a unique intra-operative Gamma Camera fused with optical vision, and the revolutionary Mammi PET, a breast cancer diagnostic device capable of visualizing small lesions and quantifying tumor activity, essential for treatment follow-up. Oncovision also offers Wprobe, an extraordinary gamma probe, the gold standard in radioguided surgery, and completes its portfolio with CareMiBrain, a dedicated brain PET that will change the way Alzheimer’s disease is diagnosed worldwide.

Oncovision has distinguished itself through the ability to successfully develop and bring to market innovative products that generate significant benefits for patients, and is committed to continuing that trend. Additionally, the company plans to bring forth technical and clinical solutions for accurate cancer diagnosis and treatment, providing the highest-quality, best-performing products.